Blood sugar stability and heart health in type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study looks at how well your blood sugar stays in the target range and whether it's linked to the health of your blood vessels and heart. You would use a continuous glucose monitor, and the results may help improve care for people with type 1 diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 7 years old.
- You must have been diagnosed with type 1 diabetes for more than a year.
- You need to use multiple daily insulin injections (not an insulin pump), with a total daily dose above 8 units.
- Your most recent HbA1c (a blood test measuring average blood sugar) must be less than 12.5%.
- You should have had no diabetic ketoacidosis (a serious complication) in the past 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using an automated insulin delivery system (a smart pump that adjusts insulin based on sensor readings) can help improve blood sugar control and bone health in adults with Type 1 diabetes who have high and unstable blood sugars.
This study tests an “artificial pancreas” system that automatically helps control insulin to reduce wide swings in blood sugar. It also aims to see whether steadier sugars can improve heart health in adults with type 1 diabetes.
This study tests a new extended-wear sensor that helps track glucose levels continuously. It is designed to see if a next-generation sensor is accurate and safe for people with diabetes.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This trial tests a new continuous glucose monitor (a small sensor that checks blood sugar levels) to see how well and safely it works in people with type 1 diabetes. You'll wear the sensor for 15 days and attend three clinic visits to check its accuracy against blood samples.
This study compares two ways of tracking blood sugar in people with type 2 diabetes who use insulin. It aims to see if one method helps manage glucose better, which could improve daily control and long-term health.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.